phenoxybenzamine has been researched along with prochlorperazine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Graybiel, A; Wood, CD | 1 |
| Deane, FR; Graybiel, A; Wood, CD | 1 |
1 review(s) available for phenoxybenzamine and prochlorperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for phenoxybenzamine and prochlorperazine
| Article | Year |
|---|---|
Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
Topics: Adolescent; Adult; Amphetamine; Antiemetics; Benzamides; Chlorpromazine; Clinical Trials as Topic; Cyclizine; Dimenhydrinate; Drug Synergism; Ephedrine; Humans; Male; Meclizine; Meprobamate; Motion Sickness; Phenothiazines; Phenoxybenzamine; Piperazines; Prochlorperazine; Promethazine; Scopolamine; Thiethylperazine | 1968 |
Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room.
Topics: Adolescent; Adult; Aerospace Medicine; Antiemetics; Cyclizine; Dextroamphetamine; Humans; Male; Meclizine; Motion Sickness; Phenoxybenzamine; Placebos; Prochlorperazine; Scopolamine | 1967 |
3 other study(ies) available for phenoxybenzamine and prochlorperazine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |